Related Experiment Videos
AAEM case report #29: Prolonged paralysis after neuromuscular blockade
1Department of Physical Medicine and Rehabilitation, University of Utah, Salt Lake City, USA.
Muscle & Nerve
|September 1, 1995
Summary
Prolonged use of nondepolarizing neuromuscular blocking agents (NMBA) in critically ill patients can lead to myopathy, causing extended muscle weakness. This condition results in significant respiratory compromise and prolonged hospital stays.
Area of Science:
- Critical Care Medicine
- Neurology
- Pathology
Background:
- Nondepolarizing neuromuscular blocking agents (NMBA) are increasingly used in intensive care settings.
- Long-term NMBA administration is associated with prolonged muscle weakness in critically ill patients.
Observation:
- Patients present with flaccid paralysis, preserved cognition, and sensation after extended NMBA use.
- Electrodiagnostic studies reveal decreased M-wave amplitudes and myopathic changes.
- Muscle biopsies show fiber atrophy, necrosis, and myofilament loss.
Findings:
- Prolonged weakness (weeks to months) suggests a myopathy, distinct from short-term blockade.
- This NMBA-induced myopathy is often linked to concurrent corticosteroid use.
- Histopathological findings confirm significant muscle damage.
Implications:
- NMBA-induced myopathy complicates ventilator weaning and prolongs hospitalization.
- Early recognition and management are crucial for patient recovery.
- Understanding this complication is vital for optimizing critical care protocols.